Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-08-10 3:57 pm Purchase | 2023-07-31 | 13G | Forte Biosciences, Inc. FBRX | Farallon Capital Partners, L.P. | 151,505 9.900% | 151,505 (New Position) | Filing History |
| 2023-08-10 09:20 am Unchanged | 2023-08-18 | 13D | Forte Biosciences, Inc. FBRX | ATG Fund II LLC | 58,480 4.000% | 0 (Unchanged) | Filing History |
| 2023-08-03 4:31 pm Sale | 2023-08-01 | 13D | Forte Biosciences, Inc. FBRX | Camac Fund LP | 52,671 3.600% | -19,837 (-27.36%) | Filing History |
| 2023-07-06 4:08 pm Unchanged | 2023-07-06 | 13D | Forte Biosciences, Inc. FBRX | Funicular Funds, LP | 81,279 9.650% | 0 (Unchanged) | Filing History |
| 2023-07-05 4:54 pm Unchanged | 2023-07-03 | 13D | Forte Biosciences, Inc. FBRX | Camac Fund LP | 72,508 8.600% | 0 (Unchanged) | Filing History |
| 2023-05-25 3:49 pm Unchanged | 2023-05-25 | 13D | Forte Biosciences, Inc. FBRX | Camac Fund LP | 72,508 8.600% | 0 (Unchanged) | Filing History |
| 2023-04-10 08:05 am Purchase | 2023-03-30 | 13G | Forte Biosciences, Inc. FBRX | JEC II Associates, LLC | 45,640 5.430% | 45,640 (New Position) | Filing History |
| 2023-03-29 11:17 am Purchase | 2023-03-24 | 13D | Forte Biosciences, Inc. FBRX | BML Investment Partners, L.P. | 69,403 8.260% | 10,948 (+18.73%) | Filing History |
| 2023-02-21 5:15 pm Purchase | 2023-02-17 | 13D | Forte Biosciences, Inc. FBRX | Camac Fund LP | 72,508 8.600% | 5,421 (+8.08%) | Filing History |
| 2022-09-28 5:22 pm Purchase | 2022-09-26 | 13D | Forte Biosciences, Inc. FBRX | Camac Fund LP | 67,087 8.200% | 9,016 (+15.53%) | Filing History |
| 2022-09-22 09:01 am Purchase | 2022-09-15 | 13D | Forte Biosciences, Inc. FBRX | Funicular Funds, LP | 81,279 9.990% | 15,998 (+24.51%) | Filing History |
| 2022-09-12 5:11 pm Sale | 2022-08-31 | 13G | Forte Biosciences, Inc. FBRX | MORGAN STANLEY MS | 9,084 1.100% | -35,365 (-79.56%) | Filing History |
| 2022-08-24 4:20 pm Purchase | 2022-08-24 | 13D | Forte Biosciences, Inc. FBRX | Funicular Funds, LP | 65,281 8.000% | 6,826 (+11.68%) | Filing History |
| 2022-08-18 09:04 am Unchanged | 2022-08-17 | 13D | Forte Biosciences, Inc. FBRX | Camac Fund LP | 58,071 7.100% | 0 (Unchanged) | Filing History |
| 2022-08-16 08:22 am Purchase | 2022-08-15 | 13D | Forte Biosciences, Inc. FBRX | BML Investment Partners, L.P. | 58,455 7.200% | 4,759 (+8.86%) | Filing History |
| 2022-08-08 8:24 pm Purchase | 2022-08-05 | 13D | Forte Biosciences, Inc. FBRX | Camac Fund LP | 58,071 9.800% | 13,552 (+30.44%) | Filing History |
| 2022-08-04 4:30 pm Purchase | 2022-07-25 | 13D | Forte Biosciences, Inc. FBRX | ATG Fund II LLC | 58,480 9.900% | 58,480 (New Position) | Filing History |
| 2022-08-01 3:10 pm Purchase | 2022-07-25 | 13D | Forte Biosciences, Inc. FBRX | Camac Fund LP | 44,519 7.500% | 44,519 (New Position) | Filing History |
| 2022-07-19 4:30 pm Purchase | 2022-07-15 | 13D | Forte Biosciences, Inc. FBRX | Funicular Funds, LP | 58,455 9.900% | 58,455 (New Position) | Filing History |
| 2022-07-08 4:56 pm Sale | 2022-06-30 | 13G | Forte Biosciences, Inc. FBRX | BlackRock Inc. BLK | 8,562 1.500% | -24,121 (-73.80%) | Filing History |